FDA’s final guidance on DCTs adds clarity on HCP task log, inspection requirements, data variability
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesClinical TrialsDecentralized clinical trialsPharmaceuticalsUnited StatesRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesClinical TrialsDecentralized clinical trialsPharmaceuticalsUnited States